Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Aug;1866(1):12-22.
doi: 10.1016/j.bbcan.2016.05.001. Epub 2016 May 5.

Recent advances in SCF ubiquitin ligase complex: Clinical implications

Affiliations
Review

Recent advances in SCF ubiquitin ligase complex: Clinical implications

Nana Zheng et al. Biochim Biophys Acta. 2016 Aug.

Abstract

F-box proteins, which are subunit recruiting modules of SCF (SKP1-Cullin 1-F-box protein) E3 ligase complexes, play critical roles in the development and progression of human malignancies through governing multiple cellular processes including cell proliferation, apoptosis, invasion and metastasis. Moreover, there are emerging studies that lead to the development of F-box proteins inhibitors with promising therapeutic potential. In this article, we describe how F-box proteins including but not restricted to well-established Fbw7, Skp2 and β-TRCP, are involved in tumorigenesis. However, in-depth investigation is required to further explore the mechanism and the physiological contribution of undetermined F-box proteins in carcinogenesis. Lastly, we suggest that targeting F-box proteins could possibly open new avenues for the treatment and prevention of human cancers.

Keywords: F-box protein; Human cancer; Oncoprotein; Tumor suppressor; Ubiquitin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A schematic illustration of the E1-E2-E3 cascade-mediated ubiquitin transfer process.
Figure 2
Figure 2
A schematic illustration of structural organization of the multiple-subunit SCF E3 ubiquitin ligase complexes.

Similar articles

Cited by

References

    1. Nalepa G, Rolfe M, Harper JW. Drug discovery in the ubiquitin-proteasome system. Nature reviews. Drug discovery. 2006;5:596–613. - PubMed
    1. Bedford L, Lowe J, Dick LR, Mayer RJ, Brownell JE. Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nature reviews. Drug discovery. 2011;10:29–46. - PMC - PubMed
    1. Bhattacharyya S, Yu H, Mim C, Matouschek A. Regulated protein turnover: snapshots of the proteasome in action. Nature reviews. Molecular cell biology. 2014;15:122–133. - PMC - PubMed
    1. Skaar JR, Pagan JK, Pagano M. SCF ubiquitin ligase-targeted therapies. Nature reviews. Drug discovery. 2014;13:889–903. - PMC - PubMed
    1. Spratt DE, Walden H, Shaw GS. RBR E3 ubiquitin ligases: new structures, new insights, new questions. Biochem J. 2014;458:421–437. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources